MS-553, a Selective PKC-ß Inhibitor Inhibits BCR Signaling and Synergizes with Venetoclax for the Treatment of High Risk CLL

Autor: Singh, Jyotsana *, Diaz Rohena, Daisy *, Liu, Chaomei *, Slawin, Bailey *, Ravikrishnan, Janani, Jain, Nitin, Wierda, William G., Zhang, Kai *, Niesman, Michael *, Woyach, Jennifer A., Sampath, Deepa
Zdroj: In Blood 15 November 2022 140 Supplement 1:9857-9858
Databáze: ScienceDirect